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Abstract
Pseudomonas aeruginosa is well adapted to the hospital setting and can cause a wide array of nosocomial infections that occasionally cul-
minate in recalcitrant outbreaks. In the present study, we describe the ﬁrst nosocomial outbreak of infection caused by blaVIM-2-positive
P. aeruginosa in Germany. In November and December 2007, highly resistant P. aeruginosa isolates were recovered from the urine of 11
patients in the Department of Urology of a University Hospital. Bacterial isolates were typed by multilocus sequence typing and
screened for known metallo-b-lactamase (MBL) genes by PCR. Environmental sources of transmission were tested for bacterial contam-
ination using surveillance cultures. Furthermore, a matched case–control study was performed in search of medical procedures signiﬁ-
cantly associated with case status. Typing of recovered isolates conﬁrmed VIM-2 MBL-producing P. aeruginosa of sequence type 175 in
all cases. Surveillance cultures did not lead to the identiﬁcation of an environmental source of the outbreak strain. Case–control analysis
revealed retrograde urography as the only exposure signiﬁcantly associated with case status. The analyses suggest the transmission of a
single clone of VIM-2 MBL-producing P. aeruginosa leading to the infection of 11 patients within 47 days. Events in temporal proximity
to retrograde urographies appear to have facilitated infection in the majority of cases. Department-speciﬁc infection control measures,
including reinforced hygiene procedures during retrograde urography, quickly terminated the outbreak.
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Pseudomonas aeruginosa is considered as a classical nosoco-
mial pathogen that is able to prevail in the hospital setting as
a result of its resistance against many antibiotics and disinfec-
tants [1]. It can cause a wide array of hospital-associated dis-
eases, including respiratory tract infections, urinary tract
infections (UTI), wound infections and bacteraemia [2]. In
addition to its intrinsic resistance against anti-infectives,
P. aeruginosa readily develops resistance against different anti-
biotic classes by mutation or acquisition of exogenous resis-
tance determinants [3].
The plethora of resistance mechanisms exploited by
P. aeruginosa include the production of a wide variety of b-lac-
tamases (AmpC cephalosporinases, OXA b-lactamases, etc.),
outer membrane protein changes (e.g. OprD loss), produc-
tion of aminoglycoside-modifying enzymes, mutations in genes
encoding topoisomerases (e.g. gyrA) and overproduction of
efﬂux pumps (e.g. MexAB-OprM) [1]. As for the b-lactamas-
es, carbapenemase production has caused considerable con-
cern in recent years because it confers resistance to virtually
all b-lactam antibiotics, leading to a critical narrowing of ther-
apeutic options. Carbapenem-hydrolyzing enzymes are
grouped into several molecular classes. They utilize either
serine or zinc at their active sites and are inhibited by clavul-
anic acid or chelators such as EDTA, respectively [4]. Metal-
lo-b-lactamases (MBLs), as the zinc-dependent enzymes are
called, are the most common carbapenemases in P. aeruginosa
and include the variants of IMP, VIM, SPM, GIM and SIM [4,5].
Although SPM, GIM and SIM MBLs have not been detected
beyond their countries of origin, VIM and IMP continue to be
detected worldwide [4]. Speciﬁcally, VIM-2, ﬁrst described in
France in 1996 [6], has gained particular notoriety as the
most-reported MBL worldwide [5].
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Horizontal spread of MBL-encoding genes (bla genes), as
demonstrated by recent inter-species dissemination of
blaVIM-2 [7], is facilitated through their location on plasmids
or transposons as part of gene cassettes within class 1
integrons [8]. At these sites, bla genes are frequently asso-
ciated with genes that confer resistance to aminoglycosides
[9,10].
Unfortunately, the accumulation of multiple resistance
mechanisms leading to the emergence of virtually pan-resis-
tant isolates has become a reality in many medical centres
[1], emphasizing the particular importance of preventive and
control measures.
Portable typing methods with sufﬁcient discriminatory
power are important for the assessment and reporting of
outbreaks and additionally facilitate interlaboratory compari-
son. Multilocus sequence typing (MLST), initially designed for
reproducible and portable typing of Neisseria meningitidis [11],
was shown to afford a high level of discrimination among
P. aeruginosa in the hospital setting, yet was expectedly less
discriminatory than the poorly portable reference standard
pulsed-ﬁeld gel electrophoresis [12].
The present study describes the evolution and successful
management of a recent nosocomial outbreak affecting the
Department of Urology in a German university hospital
and reveals a signiﬁcant association of cases with examina-
tions involving the retrograde instillation of contrast dye
into the urinary tract (i.e. retrograde cystourethrography
and pouchography). Although MBL-producing P. aeruginosa
isolates have been sporadically reported in Germany [13–
15], to our knowledge, outbreaks have not yet been
described.
Materials and Methods
Bacterial strains and cases
Bacterial isolates were recovered from the urine of patients
at the University Hospital of Wuerzburg in November and
December 2007. Urinary leukocytes were quantiﬁed by a
dipstick method (Combur 2 Test LN; Roche Diagnostics,
Mannheim, Germany). In total, 11 representative isolates
grown from urine samples from 11 patients were analysed at
the Institute for Hygiene and Microbiology. Ten of 11 cases
were inpatients at the Department of Urology, whereas one
patient (case 7; Table 1) was an inpatient at the Medical
Department, but looked after by physicians of the Depart-
ment of Urology. The age of cases (eight males, three
females) was in the range 26–75 years (Table 1).
Species identiﬁcation was accomplished using Vitek 2 GN
cards (bioMe´rieux, Nu¨rtingen, Germany).
Susceptibility testing
All strains underwent susceptibility testing using the Vitek 2
AST-N021 panel (bioMe´rieux). Additional antimicrobials
(amikacin, colistin and aztreonam) were tested by disk diffu-
sion on Mueller–Hinton agar. The MIC for colistin was
determined with the Etest (AB Biodisk, Solna, Sweden) on
Mueller–Hinton agar. The zone diameter and MIC interpre-
tive standards for breakpoints for P. aeruginosa were those
of the CLSI [16].
Detection of metallo-b-lactamases and typing
After boiling of bacterial suspensions, primers IMP-A, IMP-B,
VIM2004A, VIM2004B, SPM-1A and SPM-1B were used for
ampliﬁcation of IMP-, VIM- and SPM-type MLB genes [17],
whereas the detection of GIM-type MBLs was attempted
with primers GIMF and GIMR [13]. Strains AV65 [18] and
TS832347 [19] served as positive controls for the ampliﬁca-
tion of MBL-genes belonging to IMP and VIM family, respec-
tively. Products obtained with VIM primers were sequenced
using ampliﬁcation primers. VIM-types were identiﬁed using
BLAST (http://www.ncbi.nlm.nih.gov/BLAST/). MLST was per-
formed according to published protocols [20].
Surveillance cultures
For processing of tap water: 500 lL was plated on Columbia
blood and MacConkey agar, whereas 1 mL was additionally
mixed into 15 mL of thioglycolate broth for enrichment cul-
ture. Liquid samples (e.g. liquid soap) were diluted in double-
concentrated thioglycolate broth if the total volume was
<100 mL or otherwise ﬁltered using sterile membranes
(0.45 lm pore size; Millipore, Schwalbach, Germany) fol-
lowed by transfer of ﬁlters onto brain–heart infusion agar.
Gels (e.g. ultrasound contact gel) and other semi-solid sub-
stances were added to thioglycolate broth at a 1:9 ratio.
Microbial surface-monitoring was conducted using ‘Replicate
TABLE 1. List of case patients in chronological order of





1 M 56 Urine (7)
2 F 75 Urine (5)
3 M 64 Urine (3)
4 M 62 Urine (2)
5 M 65 Urine (3), skin (1),
wound (1)
6 F 67 Urine (1)
7 M 25 Urine (1)
8 M 66 Urine (2)
9 M 72 Urine (4)
10 F 71 Urine (1)
11 M 54 Urine (1)
M, male; F, female.
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Organism Detection and Counting’ plates containing nutrient
agar supplemented with disinfectant-inactivating additives
(Tween) where appropriate. All samples were incubated for
at least 48 h at 37C without CO2.
Case–control study
In total, 22 control patients were matched to cases at a 2:1
ratio according to sex, age (by decade), time of admission,
medical unit and the availability of urine culture results. Spe-
ciﬁcally, controls comprised those inpatients at the Urologi-
cal Department in November and December 2007 who
yielded a growth of bacteria other than the outbreak strain
from urine samples. Conditional logistic regression analysis
of matched case–control groups was performed with special
consideration of the small data set according to the method
reported by Heinze and Puhr [21]. ORs were estimated
from univariable and bivariable models. p-values were cor-
rected for multiple testing using the step-down Bonferroni
method.
Results
Timeline of the outbreak
Within 47 days in November and December 2007, multire-
sistant P. aeruginosa was isolated from the urine of 11 inpa-
tients under the care of the Department of Urology. Urine
leukocytes of seven patients were quantiﬁed as ‘++’ or ‘+++’
[levels ‘0’, ‘(+)’, ‘+’, ‘++’, ‘+++’ designating presence of none,
scanty, scanty–moderate, moderate and abundant leukocytes,
respectively]. In four of 11 patients (cases 2, 5, 6 and 11),
leukocytes could not be quantiﬁed because only dip-slides
but no native samples were received. In case 5, isolates were
additionally obtained from a wound and a skin specimen
(Table 1).
Susceptibility testing
All strains showed broad resistance against b-lactams except
aztreonam. MICs of imipenem and ceftazidime were ‡16 and
‡64 mg/L, respectively, for all strains. MICs for meropenem
and piperacillin were between 8 to ‡16 mg/L and 32 to
‡128 mg/L, respectively. Moreover, the outbreak strain dis-
played resistance against gentamicin (MIC ‡ 16 mg/L), tobra-
mycin (‡16 mg/L) and ciproﬂoxacin (‡4 mg/L). Isolates were
susceptible to colistin according to Etest (0.75 mg/L), and
suceptible to aztreonam and amikacin, as determined by disk
diffusion testing. Of note, the above resistance proﬁle (imipe-
nem MIC ‡ 16 mg/L and ceftazidime MIC ‡ 64 mg/L associ-
ated with in vitro susceptibility to aztreonam, amikacin and
colistin) had not been observed previously in our hospital.
Molecular characterization and typing
PCR with primers VIM2004A and VIM2004B ampliﬁed a
product of 380 bp in all outbreak isolates.
Ampliﬁcation of IMP-, GIM- or SPM-type MBL genes were
negative. Sequencing of the PCR products obtained con-
ﬁrmed the presence of blaVIM-2 in all isolates. All strains were
of sequence type (ST)-175, as determined by MLST. The
presence of VIM-2 represented an epidemiological novelty,
and was not detected in bacterial isolates from the Univer-
sity Hospital before November 2007.
Surveillance cultures
In total, 56 contact plates, 37 water samples, four ultrasound
contact gels and eight other liquid samples were analysed
between 38 and 65 days after recognition of the ﬁrst case.
Contact plates were made from the ﬂoor, door handles,
stretchers, ultrasound devices, a transrectal ultrasound trans-
ducer, X-ray aprons, water sinks, shower heads and surfaces
within easy reach of patients (e.g. telephone handsets, bed-
side lockers) from the two outbreak wards, the urological
intermediate care unit and two outpatient ofﬁces used for
cystoscopy and retrograde urography. Water samples and
contact gels were obtained from two urological wards, and
the urological intermediate and intensive care units.
Finally, other liquid samples comprised liquid soap from one
urological ward, rinsing run-off from the biopsy channel of a
transrectal probe, disinfection solutions, saline and two
opened contrast dyes (Imeron) used for retrograde uro-
graphy. Notably, the dyes were analysed in week 51 only
(Fig. 1). All samples failed to yield multiresistant P. aeruginosa.
Matched case–control study
A case–control study was made to evaluate exposures based
on data extractable from the hospital information system
(HIS). These encompassed chest X-ray, abdominal X-ray,
investigations involving retrograde instillation of contrast dye
into the urinary tract (retrograde urography), micturition
cysturethrogram, any surgery under general anesthesia, sonog-
raphy, intravenous pyelography, radionuclide imaging of the
kidney, abdominal computer-assisted tomography with con-
trast dye, cystoscopy and contrast dye enema. After identiﬁy-
ing retrograde urography as the strongest univariate predictor
(OR 10; Table 2), we performed bivariable analyses including
retrograde urography and each of the other variables in turn.
Only retrograde urography was signiﬁcant in each of these
models. The strongest confounders of the effect of retrograde
urography on case–control status were abdominal X-ray and
surgery (Table 3). Nevertheless, retrograde urographies were
performed only after the ﬁrst cultural detection of the out-
break strain in two cases (cases 5 and 10; Fig. 1).
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Even though the crude odds ratio remained signiﬁcant
after reanalysis categorizing these cases as ‘not exposed’
(OR 8.34, 95% CI 1.37–68.85), the reversed temporal
sequence in two cases suggests that events in temporal
proximity to retrograde investigations are the true sources
of transmission.
Implementation of control measures
Speciﬁc control measures as listed in Table 4 were proposed
at week 50 (Fig. 1) in addition to general measures, including
the isolation of cases and strict adherence to hand hygiene
guidelines. Actions regarding the performance of retrograde
urography (Table 4) were introduced only after conducting a
tentative case–control study after case 11. Thereafter, no
further transmission related to the outbreak occurred.
Despite heightened surveillance, only two additional sporadic
MBL isolates were recovered from the previously concerned
wards in the 18 months after the outbreak.
Discussion
The present study describes the detection, assessment and
successful termination of an outbreak of UTI caused by VIM-
2-producing P. aeruginosa belonging to ST-175. Given that
MBL-producing bacteria are known to cause recalcitrant hos-
pital epidemics lasting months [18] or years [9], the tempo-
rally conﬁned emergence of the outbreak strain over
<2 months likely reﬂects the effectiveness of the imple-
mented control measures (Table 4). Successful control was
greatly facilitated by an interdisciplinary approach involving
medical microbiologists, the infection control team and ward
staff.
The isolation of isolates with a unique resistance proﬁle,
sequence type (ST-175) and bla gene (i.e. bla VIM-2) strongly
supports the transmission of a single clone between cases.
ST-175 has been associated with multidrug-resistance (but
not MBL production) in clinical isolates from Hungary [22].
Although sudden increases in bacterial detection rates in one
type of specimen can represent pseudo-outbreaks resulting
from contaminated equipment used for collection, several
points suggest that the described accumulation of cases rep-
resents an outbreak of true infections. First, pyuria was con-
ﬁrmed in all cases where native samples were sent for
culture. Second, the outbreak strain continued to be
TABLE 2. Univariate OR estimates
Variable OR Lower 95% CI Upper 95% CI Corrected p-value
retr 10.04 2.26 94.50 0.0156
op 13.33 1.42 1777.44 NS
axr 3.42 0.61 35.47 NS.
ctabd 3.67 0.56 39.06 NS
cxr 2.90 0.57 29.35 NS
cyst 2.68 0.38 29.79 NS
sono 1.53 0.43 5.90 NS
age 0.78 0.22 1.59 NS
rnucl 2.00 0.16 24.62 NS
enema 1.29 0.27 5.47 NS
ivp 1.08 0.26 3.79 NS
mcu 1.00 0.14 7.32 NS
Variables investigated: retr, retrograde urography; op, any surgery involving general anaesthesia; axr, abdominal X-ray;
ctabd, computer tomography of the abdomen with contrast dye; cxr, chest X-ray; cyst, cystoscopy; sono, any sonog-
raphy; age, age in decades; rnucl, radionuclide imaging of the kidney; enema, contrast dye enema; ivp, intravenous
























FIG. 1. Temporal succession of culture-based detection of VIM-2
metallo-b-lactamase-producing P. aeruginosa in case patients 1–11,
tiled vertically. Horizontal grey bars represent the duration of admis-
sion. Full black squares and open triangles indicate timepoints of ﬁrst
cultural identiﬁcation of the outbreak strain and retrograde urogra-
phy, respectively.
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detected in several case patients (but not in other patients
of the same department) in follow-up investigations after dis-
charge (data not shown).
We were unable to determine an environmental source
of the outbreak by surveillance cultures of samples from hos-
pital wards (e.g. from tap water, water sinks, shower heads,
liquid soap, hand disinfection solution), clinical appliances
(e.g. ultrasound devices, contact gels) and operating room
equipment (e.g. saline for irrigation, contrast dyes for retro-
grade urography, X-ray aprons). Several studies reported the
conﬁrmation by culture of the sources of infection with
P. aeruginosa, which included a contaminated Bigelow’s evacu-
ator used for litholapaxies [23], an inadequately processed
cystoscope [24] and a needle guide used for transrectal,
ultrasound-guided prostate biopsies [25]. Cystoscopes were
not investigated in the present study because hospital guide-
lines demand automated processing in cleaning and disinfec-
tion devices followed by steam and plasma sterilization for
rigid and ﬂexible variants, respectively. The are several possi-
ble reasons for failure to locate the source of infection by
means of surveillance cultures: (i) surveillance cultures were
started too late in the course of the outbreak; (ii) dates and
locations of sampling had been arranged beforehand with
hospital staff; and (iii) contamination might have been tempo-
rary and/or light, possibly affecting few disposable items such
as irrigation saline or contrast dyes in an early phase of the
outbreak. Furthermore, transient colonization of hands, as
exempliﬁed in a Belgian outbreak of a panresistant P. aerugin-
osa [26], was not screened for in the present study.
A case–control study was performed in search of expo-
sures signiﬁcantly associated with case status. Because previ-
ous studies have implicated medical procedures in
transmission [23–25], we evaluated several investigations
extractable from the HIS. Although urinary catheterization
represents a recognized mode of infection, it was not
included in the analysis, because it cannot be expected to be
discriminatory in urological wards, and it is not recorded in
the HIS. Analysis revealed only retrograde urographies (ret-
rograde cystourethrographies and pouchographies) to be
independently associated with case status. Although this
implies transmission of MBL-producing P. aeruginosa during
retrograde urographies, several arguments put into question
a hard and fast causal relationship: (i) only ten of 11 cases
underwent this procedure and (ii) two cases had retrograde
urographies only after the ﬁrst positive culture of the out-
break strain (Fig. 1). Although neither point renders the
above association insigniﬁcant, it demonstrates our inability
to sharply delineate a single procedure or investigation
responsible for the spread of the outbreak strain. Presum-
ably, the majority of transmission events were directly
caused by the procedure or occurred in its temporal prox-
imity. Of note, the substantial temporal overlap of the admis-
sion periods of cases (Fig. 1) most likely allowed for further
indirect transmissions independent of retrograde urogra-
phies. Nevertheless, the termination of the outbreak only
after the introduction of control measures speciﬁcally target-
ing retrograde urography provides further support for the
assumption that the identiﬁed risk factor was responsible for
at least a fraction of the transmissions.
TABLE 3. OR estimates from a
bivariable model including ‘retr’
and adjusting for each of the other
variables in turn
Variable Adjusted by OR Lower 95% CI Upper 95% CI Corrected p-value
retr age 9.48 2.06 99.24 0.0161
retr cxr 8.53 1.86 81.36 0.0161
retr mcu 7.69 1.96 65.35 0.0161
retr axr 19.00 2.50 2455.89 0.0120
retr op 6.01 1.28 55.51 0.0214
retr sono 14.77 2.73 202.69 0.0066
retr ivp 8.63 2.09 73.57 0.0144
retr rnucl 7.41 1.92 48.71 0.0161
retr ctabd 8.37 1.94 72.90 0.0161
retr enema 11.01 2.36 109.65 0.0120
retr cyst 7.46 1.86 62.14 0.0161
retr, retrograde urography; op, any surgery involving general anaesthesia; axr, abdominal X-ray; ctabd, computer
tomography of the abdomen with contrast dye; cxr, chest X-ray; cyst, cystoscopy; sono, any sonography; age, age in
decades; rnucl, radionuclide imaging of the kidney; enema, contrast dye enema; ivp, intravenous pyelography; mcu,
micturition cysturography.
TABLE 4. List of speciﬁc measures introduced in response
to the outbreak
List of department-speciﬁc control measures
Hand disinfection prior to tapping bottles with sterile content (contrast dyes,
i.v. ﬂuids)
Procurement of additional one-way aprons for isolation rooms to prevent
shortage
Standing time of saline used for deblocking of urinary catheters limited to
24 h at room temperature
Mandatory wearing of sterile gloves and fresh surgical gowns when performing
retrograde urography
Change of wound dressing to be carried out by surgical ofﬁcer accompanied
by nursing staff
Distribution of the list of case patients to affected wards to facilitate isolation
upon readmission
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The present report has several limitations: (i) an environ-
mental source of infection could not be determined by cul-
ture-based methods and (ii) the low number of cases makes
statistical inference difﬁcult (e.g. by obviating the application
of multivariate analysis). Furthermore, outbreaks associated
with retrograde urographies have not been described,
although a small risk, speciﬁcally of UTI with P. aeruginosa,
was suggested in paediatric patients after voiding cystoureth-
rography [27].
In conclusion, the present study provides the ﬁrst descrip-
tion of a clonal outbreak of MBL-producing P. aeruginosa in
Germany and highlights the importance of epidemiologic
assessment in addition to microbiologic investigations for the
formulation of department-speciﬁc control measures aiming
to limit unwanted nosocomial transmission.
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